DR. LAL PATHLABS LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,648 INR | +0.78% |
|
+0.82% | +2.72% |
| 14/05 | Nomura Upgrades Dr. Lal Pathlabs to Buy From Neutral, Adjusts Price Target to INR2,713 From INR2,505 | MT |
| 13/05 | Dr. Lal Pathlabs' Fiscal Q4 Consolidated Net Profit Rises; Share Up 6% | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Medical & Diagnostic Laboratories
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 263.49Cr | ||||||
| 776.06Cr | ||||||
| 433.23Cr | - | - | ||||
| 264.08Cr | ||||||
| 216.15Cr | ||||||
| 175.09Cr | - |
